Billion-dollar vaccine subsidy. Donors reject proposed changes aimed at pushing down price

Donors refuse to ring-fence the remaining money in a billion-dollar pneumonia vaccine fund and give it to an Indian pharmaceutical that can push down the price dramatically. Most of the money has gone to the two big pharma companies, GSK and Pfizer, which dominate the market and, critics say, prevent price competition.